'JEDI' technology awakens new understanding of how immune system works

by The Mount Sinai Hospital3D rendering of a T cell. Credit: CC BY 3.0, Blausen.com staff. "Blausen gallery 2014". Wikiversity Journal of Medicine. DOI:10.15347/wjm/2014.010. ISSN 20018

Updated on: April 16,2024

'JEDI' technology awakens new understanding of how immune system works

by The Mount Sinai Hospital3D rendering of a T cell. Credit: CC BY 3.0, Blausen.com staff. "Blausen gallery 2014". Wikiversity Journal of Medicine. DOI:10.15347/wjm/2014.010. ISSN 20018

Updated on:April 16,2024

New 3-D imaging analysis technique could lead to improved arthritis treatment

by University of CambridgeJoint space in hip, knee and ankle joints as analyzed by the JSM algorithm. Credit: Tom TurmezeiAn algorithm to monitor the joints of patients with arthritis, which coul

Updated on: May 29,2024

New 3-D imaging analysis technique could lead to improved arthritis treatment

by University of CambridgeJoint space in hip, knee and ankle joints as analyzed by the JSM algorithm. Credit: Tom TurmezeiAn algorithm to monitor the joints of patients with arthritis, which coul

Updated on:May 29,2024

Smokers with rheumatoid arthritis face extra barriers to quitting

by University of OtagoSmokers who suffer from Rheumatoid Arthritis (RA) may need more targeted support to successfully quit a habit that will likely worsen their disease, latest University of Ota

Updated on: March 24,2024

Smokers with rheumatoid arthritis face extra barriers to quitting

by University of OtagoSmokers who suffer from Rheumatoid Arthritis (RA) may need more targeted support to successfully quit a habit that will likely worsen their disease, latest University of Ota

Updated on:March 24,2024

Guidance for coronary patients with ASA/NSAID sensitivity

(HealthDay)—In patients with stable chronic ischemic heart disease (CIHD) and histories of nonsevere hypersensitivity reactions to acetylsalicylic acid (ASA)/nonsteroidal anti-inflammatory drugs (NSAI

Updated on: April 08,2024

Guidance for coronary patients with ASA/NSAID sensitivity

(HealthDay)—In patients with stable chronic ischemic heart disease (CIHD) and histories of nonsevere hypersensitivity reactions to acetylsalicylic acid (ASA)/nonsteroidal anti-inflammatory drugs (NSAI

Updated on:April 08,2024

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

by La Jolla Institute for ImmunologyA multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease se

Updated on: April 24,2024

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

by La Jolla Institute for ImmunologyA multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease se

Updated on:April 24,2024

How to keep kids with food allergies safe during Halloween

by Jason HowlandCredit: Unsplash/CC0 Public DomainHalloween can be a particularly difficult time for kids with food allergies since many common candies contain one or more common allergens. The conseq

Updated on: June 25,2024

How to keep kids with food allergies safe during Halloween

by Jason HowlandCredit: Unsplash/CC0 Public DomainHalloween can be a particularly difficult time for kids with food allergies since many common candies contain one or more common allergens. The conseq

Updated on:June 25,2024

Teen vitamin D intake not related to adult RA or SLE risk

Dietary vitamin D intake during adolescence does not appear to be associated with the risk of adult-onset rheumatoid arthritis or systemic lupus erythematosus, according to research published in the D

Updated on: April 08,2024

Teen vitamin D intake not related to adult RA or SLE risk

Dietary vitamin D intake during adolescence does not appear to be associated with the risk of adult-onset rheumatoid arthritis or systemic lupus erythematosus, according to research published in the D

Updated on:April 08,2024

A metabolic enzyme as a potential new target for cancer immune therapies

by German Cancer Research CenterCredit: Unsplash/CC0 Public DomainThe metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system. This wa

Updated on: May 07,2024

A metabolic enzyme as a potential new target for cancer immune therapies

by German Cancer Research CenterCredit: Unsplash/CC0 Public DomainThe metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system. This wa

Updated on:May 07,2024

JAK signaling may be behind polymyalgia rheumatica

by Lori SolomonJanus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study publ

Updated on: April 16,2024

JAK signaling may be behind polymyalgia rheumatica

by Lori SolomonJanus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study publ

Updated on:April 16,2024

Loosening chimeric antigen receptor's grip on T-regulatory cells improves function, researchers find

by Leslie Cantu,Medical University of South CarolinaCAR and endogenous TCR/CD28 activation result in phenotypically similar Tregs. Credit:Molecular Therapy—Methods & Clinical Developme

Updated on: January 11,2025

Loosening chimeric antigen receptor's grip on T-regulatory cells improves function, researchers find

by Leslie Cantu,Medical University of South CarolinaCAR and endogenous TCR/CD28 activation result in phenotypically similar Tregs. Credit:Molecular Therapy—Methods & Clinical Developme

Updated on:January 11,2025

Tofacitinib ups rheumatoid arthritis treatment response

The addition of tofacitinib to rheumatoid arthritis treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs, according to a study published in the Aug. 20 is

Updated on: April 08,2024

Tofacitinib ups rheumatoid arthritis treatment response

The addition of tofacitinib to rheumatoid arthritis treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs, according to a study published in the Aug. 20 is

Updated on:April 08,2024

Trimethoprim-induced aseptic meningitis described

(HealthDay)—Drug-induced aseptic meningitis following trimethoprim use has been described in a research letter published online Nov. 20 in theInternational Journal of Rheumatic Diseases.Gayathir

Updated on: March 24,2024

Trimethoprim-induced aseptic meningitis described

(HealthDay)—Drug-induced aseptic meningitis following trimethoprim use has been described in a research letter published online Nov. 20 in theInternational Journal of Rheumatic Diseases.Gayathir

Updated on:March 24,2024